The known safety of BDNF and NT-3 from human studies, combined with the potential for effective local delivery to the inner ear, presents an attractive approach that should be evaluated clinically in hearing disorders, such as hidden hearing loss, where a neurotrophic mechanism may be beneficial. The gene discussed is BDNF; the disease is hearing disorder.